---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-056209"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:47:12.671719+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics upsizes ATM offering from $2.08M to $4.23M, adding $2.15M in new shares

## Summary
- Maximum aggregate offering price increased from $2,076,000 to $4,227,000 under November 2024 Sales Agreement with H.C. Wainwright.
- Current Prospectus Supplement filed June 20, 2025, registering an additional $2,151,000 of common stock.
- Approximately $2,075,688 in shares already sold under the prior ATM limit, nearly exhausting previous capacity.
- Proceeds intended for general corporate purposes; dilution impact on existing shareholders.

## SEC filing metadata
- accession: 0001213900-25-056209
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390025056209/0001213900-25-056209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390025056209/ea0246257-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-056209
- JSON: https://secwatch.observer/filing/0001213900-25-056209.json
- Plain text: https://secwatch.observer/filing/0001213900-25-056209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.